Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
1998-4-23
pubmed:abstractText
Human erythrocytes (E) react by exocytosis of membrane vesicles to various stresses including the fixation of the membrane attack complex of Complement. E from normal individuals loose a notable proportion of their initial number of surface CR1 molecules during the ageing process. An acquired decrease of CR1 on E also occurs in pathological conditions such as Systemic Lupus Erythematosus or AIDS. The present study investigated whether calcium ionophore A23187 (Ca-ion) induced vesicle formation of human E in vitro is responsible for a preferential loss of CR1 as well as whether CR1 molecules at the surface of Ca-ion treated E or vesicles are: (i) functional, (ii) native or protease degraded, or (iii) more clustered than CR1 on native E. A study of E from 137 normal individuals showed that a one-hour Ca-ion induced vesicle formation preferentially removed one third of E surface CR1. Kinetic experiments suggested that all surface CR1 could be removed from E upon longer incubation times. CR1 molecules on vesicles were still able to inhibit Complement activation, and were found in larger clusters than on native E. These data suggest that a significant part of surface CR1 molecules may be removed from E by vesicle formation during the life of E in normal individuals. This phenomenon could be exacerbated in pathological conditions.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0162-3109
pubmed:author
pubmed:issnType
Print
pubmed:volume
38
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
129-40
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed-meshheading:9476124-Aging, pubmed-meshheading:9476124-Alleles, pubmed-meshheading:9476124-Calcimycin, pubmed-meshheading:9476124-Complement C1r, pubmed-meshheading:9476124-Complement C4b, pubmed-meshheading:9476124-Complement Inactivator Proteins, pubmed-meshheading:9476124-Complement Membrane Attack Complex, pubmed-meshheading:9476124-Erythrocytes, pubmed-meshheading:9476124-Exocytosis, pubmed-meshheading:9476124-Flow Cytometry, pubmed-meshheading:9476124-Glycoproteins, pubmed-meshheading:9476124-Humans, pubmed-meshheading:9476124-Immunohistochemistry, pubmed-meshheading:9476124-Ionophores, pubmed-meshheading:9476124-Microscopy, Electron, pubmed-meshheading:9476124-Papain, pubmed-meshheading:9476124-Polymorphism, Restriction Fragment Length, pubmed-meshheading:9476124-Receptors, Complement, pubmed-meshheading:9476124-Receptors, Complement 3b, pubmed-meshheading:9476124-Synaptic Vesicles
pubmed:year
1997
pubmed:articleTitle
Catabolism of the human erythrocyte C3b/C4b receptor (CR1, CD35): vesiculation and/or proteolysis?
pubmed:affiliation
Laboratoire d'Immunologie, CHU Robert Debré, Reims, France.
pubmed:publicationType
Journal Article